Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

Page 139

SandStone rocks series B-plus round

The data storage platform developer raised $21.4m in a round led by Cosco Shipping Development that will support recruitment and market expansion.

Jul 9, 2020

Truepill fulfils $25m series B

Optum Ventures helped the prescription fulfilment platform push its total funding to more than $39m, with the cash to fund product development.

Jul 9, 2020

VarmX arms itself with $36.2m series B

Lundbeckfonden Ventures took a board seat at Leiden spinout VarmX as part of a round that will fund development of a treatment for spontaneous bleeding.

Jul 9, 2020

VelosBio sells investors on $137m series B

The cancer therapy developer boosted its overall funding to more than $200m in a round that included series A backer Takeda Ventures.

Jul 9, 2020

VarmX arms itself with series B cash

Lundbeckfonden Ventures took a board seat at VarmX as part of a $36.2m round that will fund development of a treatment for spontaneous bleeding.

Jul 9, 2020

Sayari strengthens series B round

The financial mapping software provider has added $2.5m to the SAP-backed first tranche it closed in January, taking the round to $11.5m.

Jul 8, 2020

Vor gets more in $110m series B

Stem-cell cancer treatment developer Vor Biopharma has collected more capital from investors including existing backers Johnson & Johnson and PureTech Health.

Jul 8, 2020

Vor leaps into $110m series B

Columbia University’s Vor Biopharma has collected more capital from shareholders including Osage University Partners, Johnson & Johnson and PureTech Health.

Jul 8, 2020

Meituan Dianping puts $15m into Pudu

Delivery robot developer Pudu Robotics received a series B investment by the mobile services platform in connection with a strategic partnership.

Jul 7, 2020

OxSonics sounds out $13.1m

The ultrasound therapeutics developer, a University of Oxford spinout, has raised series B2 funding in the run-up to clinical testing of its cancer drug delivery platform.

Jul 7, 2020
© 2025 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here